Research

New discoveries in lung cancer research, such as the research funded by LCFA, are resulting in new treatments for lung cancer patients

How LCFA uses your donation wisely to fight lung cancer:

You Make A Donation to LCFA
Your dollars are added to contributions from other donors




We maximize your donation by adding it to dollars from LCFA’s strategic funding partners.


This leveraged donation allows LCFA to award a generous grant to a top young lung cancer investigator for 2 years of focused and intense research.


The lung cancer investigator
can now start the critical two-year process of research and discovery

Now, armed with this new evidence, the lung cancer investigator presents their findings to organizations like the National Institutes of Health (NIH) for consideration for vital next-stage grants.

Each painstaking step brings us closer to understanding how lung cancer works, how to detect it earlier, how to fight it better, and – someday – how to cure it.



Latest In Research

07/3
2019

Clinical Trial Navigators

From The New York Times Fewer than 5 percent of cancer patients participate in research that could improve care. Clinical Trial Navigators could help patients find the right studies. Since a Phase I trial has prolonged my life for al…

06/26
2019

FDA approves Keytruda for SCLC

FDA approves Keytruda The FDA approved pembrolizumab monotherapy for patients with metastatic small cell lung cancer that progressed on or after platinum-based chemotherapy and at least one other prior line of therapy. This marks…

05/24
2019

The Relationship Between Air Pollution and Lung Cancer in Nonsmokers

From Science Direct Relationship between air pollution and lung cancer in nonsmokers - is there one? For never-smokers (smoked <100 lifetime cigarettes), lung cancer  has emerged as an important issue. We aimed to investigate the …

05/22
2019

What good is it to be able to cure cancer if we routinely fail to deliver that cure?

From MedScape 'How Could We Fail so Miserably?' Real-World Evidence Offers Sobering Reality We are doing an unconscionably poor job of delivering appropriate targeted therapies to our patients. That's the only conclusion I can draw, bas…

05/10
2019

Artificial intelligence and cancer

From Fred Hutch News Service New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations When rural Minnesota music teacher Shelly Engfer-Triebenbach started getting winded while…

05/10
2019

Know Your Genes: Testing for Genomic Mutations in Lung Cancer

From Cure Today Testing for genomic mutations in lung cancer helps pinpoint targeted therapies. Amanda Nerstad was 39 years old and a busy working mother of two young children when she learned she had metastatic lung cancer in 2016. She was…

05/7
2019

Lung Cancer Stigma: Not Just the Patient’s Problem

From MedPage Today How healthcare professionals have an impact - for better or worse. A previous Reading Room article discussed the various forms of stigma that lung cancer patients experience, including internalized negative feelings of sh…

04/30
2019

Could invigorating the immune system prevent lung cancer?

From Medical News Today Scientists have identified biological changes in apparently normal airway tissue that could potentially predict the development of lung cancer. The changes alter gene and cell activity in the immune system. A team fr…

04/3
2019

Precision of Liquid Biopsy and Osimertinib Resistance

From Globe Newswire Biodesix® will release new data demonstrating the potential diagnostic utility of a blood-based test for patients with resistance to osimertinib, and on the precision of liquid biopsy in comparison to tissue biopsy. Two…

04/2
2019

Current Open Clinical Trials

From UCLA Thoracic Oncology Translational Research Current and open clinical trials have been announced at UCLA Main Campus and various satellite centers. The trials include:  Clinical Trial: Relapsed or Refractory Small Cell Lung Cancer …



Read More